| NAME |
TOCILIZUMAB 162MG/0.9ML INJ,SYRINGE,0.9ML |
| VA GENERIC NAME |
TOCILIZUMAB |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Tocilizumab_(Actemra)_(Dec_2022).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
162 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/0.9ML |
| NATIONAL FORMULARY NAME |
TOCILIZUMAB INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
TOCILIZUMAB 162MG/0.9ML INJ SYR 0.9ML |
| VA PRODUCT IDENTIFIER |
T0839 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4032860 |
| EFFECTIVE DATE/TIME |
-
- 2013-11-19 00:00:00
- STATUS: ACTIVE
|
